8-K: Concentra Announces Strong Q4 and Full Year 2024 Results, Completes Nova Medical Centers Acquisition

Concentra reports a successful 2024 marked by revenue growth, strategic initiatives, and the acquisition of Nova Medical Centers, setting a positive outlook for 2025.

Summary

• Concentra Group Holdings Parent, Inc. announced its fourth quarter and full year 2024 financial results.
• The company also completed the acquisition of U.S. Occmed Holdings, LLC d/b/a Nova Medical Centers on March 1, 2025, for $265 million.
• Fourth quarter revenue increased 5.5% to $465.0 million, while full year revenue increased 3.4% to $1,900.2 million.
• Net income for the fourth quarter was $22.8 million, and for the full year, it was $171.9 million.
• Adjusted EBITDA increased 13.6% to $77.5 million for the fourth quarter and 4.3% to $376.9 million for the full year.
• The company's cash balance at year end was $183.3 million, with a net leverage ratio of 3.46x.
• For 2025, Concentra anticipates revenue of approximately $2.1 billion and Adjusted EBITDA in the range of $410 million to $425 million.
• Capital expenditures for 2025 are projected to be between $80 million and $90 million, with a net leverage ratio of approximately 3.5x.
• A cash dividend of $0.0625 per share was declared on February 28, 2025, payable on April 1, 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and strategic acquisitions, indicating a favorable investment opportunity.

Positives

• Revenue per visit increased by 5.8% to $145.08 in Q4 2024.
• Cash flows from operating activities in Q4 2024 totaled $93.7 million, compared to $76.2 million in the same quarter of the prior year.
• The company is targeting a net leverage ratio of approximately 3.0x within 18-24 months.
• The company has over 80 years of combined history supporting and providing occupational health services and has expanded to more than 770 occupational health centers and onsite health clinics at employer worksites located across the country.

Negatives

• Patient visits decreased by 0.5% in Q4 2024, with visits per day down by 2.1%.

Risks

• The document mentions several factors that could cause actual results to differ from forward-looking statements, including changes in regulations, labor shortages, competition, security breaches, litigation, and adverse economic conditions.
• The company's ability to achieve the expected benefits of and successfully execute the Separation and related transactions is a risk factor.
• The negative impact of public threats such as a global pandemic or widespread outbreak of an infectious disease similar to the COVID-19 pandemic is a risk factor.
• Increasing scrutiny and rapidly evolving expectations from stakeholders regarding ESG matters is a risk factor.

Future Outlook

Concentra expects revenue of approximately $2.1 billion and Adjusted EBITDA in the range of $410 million to $425 million for 2025, giving effect to the acquisition of Nova Medical Centers.

Management Comments

• Keith Newton, Chief Executive Officer of Concentra, expressed confidence in the company's ability to continue delivering strong results in 2025.
• Matt DiCanio, Concentra's President & Chief Financial Officer, noted the positive impact of the company's expanded footprint and high patient satisfaction scores.

Industry Context

The acquisition of Nova Medical Centers positions Concentra as the largest provider of occupational health services in the United States, enhancing its ability to deliver quality care and exceptional service through greater access.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• However, it highlights Concentra's position as the largest provider of occupational health services, suggesting a leading role in the industry.

Stakeholder Impact

• Shareholders will receive a cash dividend of $0.0625 per share.
• Employees will benefit from the company's growth and strategic initiatives.
• Patients will have greater access to quality care and exceptional service.
• Customers and employers will experience accelerated innovation and enhanced outcomes.

Next Steps

• Concentra is in the process of integrating Nova Medical Centers into its portfolio.
• The company will continue to focus on its development pipeline and strategic initiatives to deliver strong results in 2025.

Key Dates